Why the study?
Tricuspid valve incompetence may predispose patients with single right ventricle to unfavorable Fontan palliation results, but the long-term impact of tricuspid valve intervention remained unclear.
Does tricuspid valve intervention improve transplant- and Fontan takedown-free survival in patients with single right ventricle undergoing Fontan completion?
Does tricuspid valve intervention improve transplant- and Fontan takedown-free survival in patients with single right ventricle undergoing Fontan completion?
Repeat tricuspid valve intervention during single ventricle palliation is associated with inferior long-term outcomes, whereas successful single TV intervention provides comparable survival to patients not requiring TV surgery.
Answers are grounded in this paper and cite their sources.
TV intervention in single RV Fontan patients should not yet change practice; leaves open its long-term impact.
BACKGROUND: The incompetence of the tricuspid valve (TV) may predispose to unfavorable results of Fontan palliation in patients with single right ventricle (RV). This study aims to reveal the effect of TV intervention in patients with single RV on long-term outcomes after Fontan completion. METHODS: A single-center retrospective cohort study was conducted with patients who underwent Fontan completion from 1985 to 2017. There was a total of 678 patients with single RV. A total of 128 patients (18.8%) underwent TV intervention at any stage (TVI group); 30 of them (23.4%) underwent repeat TV surgery (repeat TVI subgroup). The control group comprises 550 patients (81.2%) who had no TV surgery regardless of the degree of TR (non TVI group). RESULTS: The median follow-up was 8.8 (± 7.6) years. Overall transplant- and Fontan takedown-free survival was 62.5% (95% CI 59.2%-64.9%) at 20 years. The repeat TVI group had significantly lower transplant and takedown-free survival rates (Non TVI 76.5% vs. Single TVI 75.3% vs. repeat TVI 56.0% at 15 years, P = 0.02). The younger age at Fontan (1.12 [95% CI 1.02-1.22], p = 0.019), repeat TVI (3.33 [95% CI 1.57-7.04], p = 0.002), TV intervention after Fontan (6.14 [95% CI 2.60-14.50], p < 0.001), significant ventricular dysfunction before Fontan (3.12 [95% CI 1.12-8.30], p = 0.028) and any concomitant procedure at Fontan (1.98 [95% CI 1.16-3.37], p = 0.013) were the significant risk factors for transplant and takedown free- survival. CONCLUSIONS: Repeat TV intervention during the Fontan was associated with inferior outcomesin patients with morphologic systemic RV. Successful TV intervention could provide comparable long-term survival outcomes to non-TV intervention patients.
No takes yet. Share an insight, caveat, or question.
Kulyabin et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: